Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2015 Jul;20(7):e23.
doi: 10.1634/theoncologist.2015-0116. Epub 2015 Jun 11.

Adjuvant Therapy Reduces Rate of Dissemination but Shortens Survival Thereafter

Michael K Fink  1 , Ulrich R Kleeberg  2 , Stefan Bartels  3
Affiliations
Comment

Adjuvant Therapy Reduces Rate of Dissemination but Shortens Survival Thereafter

Michael K Fink et al. Oncologist. 2015 Jul.

Abstract

In the subgroup of patients who suffer from metastases despite adjuvant therapy, survival after dissemination is shortened. This is partially due to an adjuvant chemotherapy-induced resistance to previous treatment and may be similar after hormonal therapy and immunotherapy.

PubMed Disclaimer

Comment on

References

    1. Xu B, Seidman A, Chan S. In reply. The Oncologist. 2015;20:88. - PMC - PubMed
    1. Fink MK, Kleeberg UR, Bartels S. Adjuvant therapy-related shortening of survival (ATRESS): An underrated phenomenon. The Oncologist. 2015;20:88. - PMC - PubMed
    1. Seidman AD, Chan S, Wang J, et al. A pooled analysis of gemcitabine plus docetaxel versus capecitabine plus docetaxel in metastatic breast cancer. The Oncologist. 2014;19:443–452. - PMC - PubMed
    1. Bonadonna G, Brusamolino E, Valagussa P, et al. Combination chemotherapy as an adjuvant treatment in operable breast cancer. N Engl J Med. 1976;294:405–410. - PubMed
    1. Palmieri C, Jones A. The 2011 EBCTCG polychemotherapy overview. Lancet. 2012;379:390–392. - PubMed